semaglutide cardiovascular outcomes news 2025 Effects of on risk of events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials | Cardiovascular Diabetology Cardiovascular Disease | Ozempic® (semaglutide)

As a research organization, every element of our work is undertaken with the millions of people living with or at risk for dementia as our driving force

Colson PH, Virsolvy A, Gaudard P et al (2016) Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: implications for its safety profile

This initial phase establishes tolerance and confirms the medication is working for appetite control

Gene expression analysis in soybean in response to the causal agent of Asian soybean rust ( Phakopsora pachyrhizi Sydow) in an early growth stage

Digital platforms that show comparative pricing at the point of prescribing reduce sticker shock, increase adherence, and enhance patient trust